Diagnostics (Sep 2023)

Hepatic Inflammatory Pseudotumor—Focusing on Its Heterogeneity

  • Soo Ryang Kim,
  • Soo Ki Kim,
  • Yu-ichiro Koma,
  • Motoko Sasaki,
  • Akira Asai,
  • Hiroki Nishikawa

DOI
https://doi.org/10.3390/diagnostics13172857
Journal volume & issue
Vol. 13, no. 17
p. 2857

Abstract

Read online

Hepatic inflammatory pseudotumors (IPTs) are defined as benign, non-malignant, non-metastasizing tumors characterized by the presence of myofibroblastic spindle cells, hetorogenous populations of inflammatory cells, particularly plasma cells, lymphocytes and macrophages, as well as locations of fibrosis and necrosis without cellular anaplasia or atypical mitoses. Despite subsequent reports in the references, hepatic IPT remains difficult to diagnose; while posing major issues specifically for its differential diagnosis compared with that of other various benign diseases and malignant hepatic tumors. Histopathological findings are always a requisite for confirming the diagnosis, particularly given that the pathogenesis of IPT remains ambiguous to date. Hepatic IPT is a heterogeneous entity in terms of its clinical features, pathological findings, and pathogenesis. Once the diagnosis is confirmed, however, needless surgery such as wedge resection and lobectomy should be avoided. Here, we discuss the heterogeneity of hepatic IPT, its clinical features, pathological findings, and pathogenesis, and describe its differential diagnosis.

Keywords